LP35848-8
Dalbavancin
Active
Description
Dalbavancin (INN, propriatory name Zeven) is a novel second-generation lipoglycopeptide antibiotic. It belongs to the same class as vancomycin, the most widely-used and one of the few treatments available to patients infected with methicillin-resistant Staphylococcus aureus (MRSA). Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details. Source: Wikipedia, Dalbavancin
Basic Part Properties
- Part Display Name
- Dalbavancin
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2005-07-07
- Construct for LOINC Short Name
- Dalbavancin
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=LP35848-8 - ConceptMap translate
- https:
//fhir.loinc.org/ConceptMap/$translate?system=http: //loinc.org&code=LP35848-8
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
zh-CN | Chinese (China) | 达巴万星 Synonyms: BI397; |
fr-CA | French (Canada) | Dalbavancine |
et-EE | Estonian (Estonia) | Dalbavantsiin |
es-ES | Spanish (Spain) | Dalbavancina |
it-IT | Italian (Italy) | Dalbavancina |
tr-TR | Turkish (Turkey) | Dalbavansin |
ru-RU | Russian (Russian Federation) | Далбаванцин |
nl-NL | Dutch (Netherlands) | dalbavancine |
fr-BE | French (Belgium) | Dalbavancine |
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright